Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Coherus Oncology (CHRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
9 analysts
Options Flow (P/C)
—
Avg Consensus PT
$7
+1713.6%
Highest Price Target
$12
+3058.7%
Lowest Price Target
$1
+176.4%
Short Interest
8.5%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Guggenheim | Paul Jeng— | +2005.8% | $10 → $8 | Maintained | Buy |
| Oct 29, 2026 | HC Wainwright & Co. | Swayampakula Ramakanth— | +1742.6% | $7 | Assumes | Buy |